Cabiasan, Khent Harrold G.
HRN: 19-96-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
CEFTRIAXONE 1G (VIAL)
11/23/2023
11/30/2023
IV DRIP
1g
Q24
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes